Skip to content
Search
By  Tedd Alexander, David Corris, CFA, Brian Dausch, CFA
Download the PDF

Are high-quality U.S. large-cap stocks overpriced?

With historically high quality, expensive large-caps could lag in an internal market rotation

July 2025, From the Field

Key Insights
  • High-quality U.S. large-cap stocks are near historically expensive levels. Our data suggest an elevated probability of underperformance in the coming quarters.
  • With historically high quality, we believe high-quality large-caps will eventually underperform in an internal market rotation rather than in a significant drawdown.
  • While large-cap growth stocks led in the second quarter, we would expect value and smaller-cap securities to outperform in a broadening quality correction.

The overriding theme of the second quarter was a historic risk‑on rally in the U.S. The quarter started with a significant sell‑off following President Donald Trump’s “Liberation Day” tariff announcements, which rapidly reversed after Trump announced a 90‑day pause with most countries. From there, investors largely looked past the looming tariffs, concerns about rising interest rates in response to renewed inflation and/or a growing federal deficit, and a war in the Middle East. Instead, investors focused on the potential stimulative effects of continued artificial intelligence (AI) innovation, the “One Big Beautiful Bill” regarding budget reconciliation, deregulation, and potential Federal Reserve interest rate cuts in the months ahead. These considerations led to exceptionally divergent factor returns in the U.S. Broadly, we highlight three themes:

  • A historically speculative quarter in the U.S., particularly in small‑cap stocks: Across the U.S. indices tracked in Figure 1, high‑risk securities generally outperformed lower‑risk securities by 10% to 20%. For historical context, this ranked in the 98th percentile in U.S. large‑caps and in the 96th percentile in U.S. small‑caps, based on rolling three‑month cap‑weighted returns since the start of 1991. For additional context, high‑quality stocks underperformed low‑quality stocks by 10% to 15%. Growth factors beat value factors by 20% to 30%, depending on the universe. These factor returns paint a picture of a high‑risk, low‑quality, speculative growth rally in which valuation concerns were not relevant. This was pronounced in small‑caps, where the least profitable stocks outperformed the most profitable stocks by approximately 10%, while the smallest companies in the small‑cap universe outperformed by more than 10%.
  • A return to AI leadership: A large part of the pro‑risk, pro‑growth rally this quarter was renewed interest in potential AI beneficiaries. We have developed “AI betas” for tracking market themes and note the extreme outperformance of the top quintile of AI exposure in the U.S. large‑cap universe (Figure 2).
  • Factor divergence between the U.S. and non‑U.S. markets: We highlight that the lower‑quality, risk‑on rally in the U.S. was much more pronounced than in non‑U.S. markets—for example, with high quality outperforming low quality in Japan and value beating growth in Europe. This is notable given that non‑U.S. markets had total returns that were competitive with the U.S. indices. We believe this reflects a combination of stimulative policies in the U.S., along with elevated “animal spirits.”
“A large part of the pro-risk, pro-growth rally this quarter was renewed interest in potential AI beneficiaries.”

Quarterly factor returns

(Fig. 1) April 1, 2025–June 30, 2025
Quarterly factor returns

Past performance is not a guarantee or a reliable indicator of future results.
Sources: Refinitiv/IDC data, Compustat, Worldscope, Russell, MSCI. Analysis by T. Rowe Price. See Additional Disclosures. Total return data are in U.S. dollars. Factor returns are calculated as equal-weighted quintile spreads. Please see Appendix for more details on the factors.

Excess returns to quintiles of T. Rowe Price calculated AI betas in the Russell 1000 Index

(Fig. 2) March 31, 2025–June 30, 2025
Excess returns to quintiles of T. Rowe Price calculated AI betas in the Russell 1000 Index

Past performance is not a guarantee or a reliable indicator of future results.
Source: FactSet. Analysis by T. Rowe Price. AI betas were developed using a proprietary approach to estimate the AI sensitivity of each stock in the Russell 1000 Index.
Actual outcomes may differ materially from estimates. Estimates are subject to change.

Market insight—What we’re monitoring

One of the most important questions we’re getting from clients is what is our view on the valuation of high‑quality U.S. large‑cap stocks. We believe that question serves as an ideal case study to illustrate the Integrated Equity approach, which is a focus of this quarter’s newsletter. Our key conclusions are:

  • High-quality U.S. large-cap stocks are historically expensive, although slightly less so following this quarter’s low-quality rally. The data suggest a still-elevated probability of underperformance in the coming quarters.
  • However, because their quality is also historically high, we expect additional underperformance—if and when it occurs—to more likely manifest as lagging in an internal market rotation, rather than as a significant drawdown.
  • We believe any future underperformance of quality would manifest differently than in the second quarter; while large-cap growth stocks led in the second quarter, we would expect value and smaller-cap securities to outperform in a broadening quality correction.

Refresher on the T. Rowe Price Integrated Equity philosophy

In many industries and professional pursuits, such as medicine, sports, law, politics, and gaming, we see “human + machine” approaches leading to superior outcomes. These trends have accelerated with the explosion of data and computing power and with research that best practices in forecasting and prediction involve base rates and blending “outside” and “inside” views to counteract behavioral biases.

“High-quality U.S. large-cap stocks are historically expensive, although slightly less so following this quarter’s low-quality rally.”

The T. Rowe Price Integrated Equity team’s core philosophy is that blending quantitative and fundamental approaches should lead to better results in investments, too. This is inextricably linked with the idea of combining outside and inside views. As a refresher:

  • The outside view uses broad, relevant historical precedents to understand what is most likely to occur in a given situation. In other words, the outside view establishes “base rates” for what has happened historically in similar situations.
  • The inside view uses the specifics of an individual situation to understand what is most likely to happen.

To illustrate:

  • For professional sports teams, choosing which players to draft combines the outside view (quantifiable metrics like height, speed, and agility) with the inside view (individualized projections from talent evaluators).
  • For economists, predicting the probability of a recession involves weighing the base rate of recessions (which are infrequent) with current economic indicators (such as gross domestic product growth and the unemployment rate).
  • For our team’s process, we combine the outside view (quantitatively analyzing how stocks with similar growth rates, profitability, and valuation have performed historically) with the inside view (fundamentally assessing corporate strategy, competitive intensity, and management quality).

We now apply that approach to evaluate the pricing of high‑quality U.S. large‑cap stocks.

Valuation of U.S. large-cap high quality: The outside view

We have developed a proprietary valuation metric that values any “factor” (group of stocks) by blending several different calculation techniques and underlying metrics. Each metric has pros and cons, but blending them produces a more robust result.

We define “quality” using a proprietary blend of factors covering three broad categories:

  • Stability: High-quality stocks exhibit more stable fundamentals and historical pricing, with more certainty around future earnings.
  • Profitability: High-quality stocks have stronger earnings and cash flow generation.
  • Debt servicing: High-quality stocks have stronger balance sheets.

Based on these inputs, our analysis suggests that high‑quality U.S. large‑cap stocks are historically expensive (Figure 3). The data are intuitive: High‑quality stocks were historically cheap during the 1998–2000 “tech bubble” and historically expensive during flights to quality leading into the 2002–2003 post‑recession junk rally, during the 2008 global financial crisis, during the  2013 ”taper tantrum” when the Fed was preparing to curtail its asset purchases, and at the height of the coronavirus pandemic.

Valuation of quality within the Russell 1000 Index

(Fig. 3) January 31, 1995–June 30, 2025
Valuation of quality within the Russell 1000 Index

Sources: Refinitiv/IDC data, Compustat, Thomson/IBES, Russell. Analysis by T. Rowe Price. The plot points represent the Z-score of our proprietary multifactor metric indicating whether quality is cheap (positive numbers) or expensive (negative numbers). Valuation is based on a variety of metrics and a proprietary methodology. Z-score is defined as the quantity of (current score minus the average of previous periods) divided by the standard deviation of previous periods. The numbers correspond to the number of standard deviations (e.g., a reading of 1 means “1 standard deviation cheap”).
See Appendix for additional details on the quality metric.

As shown in Figure 3, early in the second quarter, quality large‑cap companies were as expensive as they had been at any time in the last 30 years. Following the low‑quality rally this quarter, the expensiveness of quality has corrected by approximately one standard deviation, yet quality still appears expensive relative to history.

This relationship tends to predict underperformance of quality (Figure 4). Here, the x‑axis shows the starting valuation of quality using the relationship shown in Figure 3. The y‑axis shows the subsequent 12‑month forward return to the long‑short quality factor. The data suggest that as quality becomes expensive, on the left side of the chart, the probability and potential magnitude of future underperformance rises substantially. The June 30, 2025 reading of approximately 1.4 standard deviations expensive is shown in the red line; historically, such levels have led to a wider range of outcomes for quality securities.

Forward 12-month long-short returns to quality based on starting valuation—Russell 1000 Index

(Fig. 4) January 31, 1995–June 30, 2024
Forward 12-month long-short returns to quality based on starting valuation-Russell 1000 Index

Past performance is not a guarantee or a reliable indicator of future results.
Sources: Refinitiv/IDC data, Compustat, Thomson/IBES, Russell. Analysis by T. Rowe Price. Returns to quality are defined by a long-short quintile spread using our quality metric. Analysis based on expanding window with information known at the time to avoid look-ahead bias. In other words, when we model a particular year, we always use the full data available at that time going back to 1995. This time series requires 5 years of data to create a Z-score, so the first data point on 1/31/00 corresponds to using data back to 1/31/95. The last data point is as of 6/30/24, which uses 12-month forward data extending to 6/30/25. Valuation is based on a variety of metrics and a proprietary methodology.
See Appendix for additional details on the long-short returns/quintile spreads calculation and the quality metric.
The vertical red line shows where today’s reading would fall in the historical distribution. Quintiles are reconstituted at the end of every month. The 12-month forward return means the 12-month subsequent return. Price of quality on the X-axis is based on the relationship shown in Figure 3.
Long‑short returns to quality measure the difference between the highest and lowest quintile returns over the subsequent 12 months.

One pushback could be that this is being driven by a narrow set of companies (e.g., AI beneficiaries). We have looked at the data in multiple ways (e.g., by sector, high‑quality and low‑quality companies in isolation, market cap‑ and equal‑weighted), and the results appear to be robust. In other words, we see signs that higher‑quality stocks appear expensive across U.S. large‑cap equities, and this is not limited to mega‑cap technology stocks.

On the surface, this would suggest a potentially pessimistic outside view for the outlook for quality. However, this overstates our pessimism, as we will now discuss with the inside view.

Valuation of U.S. large-cap high quality: The inside view

There are a few reasons to partially discount the outside view shared above. First, we note three significant caveats in the above relationship:

  • All previous episodes of quality being extremely expensive have occurred after market drawdowns and flights to quality (e.g., recessions). Currently, the Russell 1000 Index is near all‑time highs following a swift recovery from the early‑April drawdown. Therefore, today’s situation looks quite different. This could imply that there are legitimate reasons for quality to screen as expensive, rather than as a market in which investors are overpaying for safety, as has happened historically.
  • Relatedly, previous extreme periods of quality underperformance have happened primarily due to the short leg rebounding—for example, after periods of stress, the low‑quality stocks that underperformed on the way down typically lead the recovery, causing a period of severe underperformance of quality. We see the chances of that as lower given the lack of a significant drawdown in those stocks in the recent past.
  • In Figure 3, we also note a trend in the valuation of quality over the past decade. As we’ve referenced in previous newsletters, there appears to have been a fundamental shift in the economy where technology, regulation, and winner‑take‑all economics have led to significant competitive advantages for larger companies. We see this reflected in the trend line, where quality companies have become progressively more expensive over the past decade. This could simply be a reflection of their superior economics. To the extent this is true, this quarter’s market environment appears to have pulled the relationship mostly—but not fully—back to the trend line.

Next, we look at those superior economics more systematically. We observe that profitability levels—and spreads versus the rest of the universe—have increased for the most profitable companies (Figure 5). In other words, the quality level of high‑quality companies today is also historically high. If their quality is even higher today than in the past, one could argue that their valuations should also be elevated relative to history.

Return on equity (ROE) levels by quintile, Russell 1000 Index

(Fig. 5) January 31, 1985–June 30, 2025
Return on equity levels by quintile, Russell 1000 Index

Sources: Compustat, Russell. Analysis by T. Rowe Price.
Quintiles based on ROE are reconstituted monthly. ROE is calculated by dividing the last 12 months’ earnings of individual companies by the average of their book value.

Finally, we note that discussions with our fundamental analysts play a large role in our evaluation of the market environment. While specific securities are outside the purview of this newsletter, we note that many of the high‑quality stocks with seemingly expensive valuations are viewed attractively by our talented analysts based on their deep inside views. These views include an understanding of these companies’ leadership positions and moats in their businesses, pricing power, secular growth potential, and management talent. In many of their bottom‑up analytical models, reasonable assumptions justify the outperformance potential for many of these companies.

Synthesis

How do we reconcile the outside and inside views? Our general conclusions are:

  • Quality looks historically expensive within the U.S. large‑cap universe.
  • These levels of valuation would historically imply meaningful chances for underperformance.
  • But we temper these concerns by noting a very different market environment today, both fundamental and quantitatively observed trends toward higher‑quality companies meriting more expensive valuations, and bottom‑up work at the firm suggesting that many of these stocks remain attractive at current valuations.

Our view is that high‑quality large‑cap companies remain somewhat expensive today, but not as much as the data suggest. We believe the probabilities are that they will underperform in aggregate at some point over the next year, but we believe it’s more likely that the underperformance will be due to the market broadening out. To the extent that current economic policies lead to continuing growth, we envision an ongoing rotation into parts of the market that have lagged over the last decade (e.g., U.S. small‑cap stocks and international stocks). In that event, we expect investors would use high‑quality U.S. large‑cap stocks as a funding source.

Of note, we are not forecasting a significant decline in high‑quality stocks. As mentioned above, severe underperformance of quality historically has been driven by the short leg. We don’t see those conditions in place today, and if there were to be a big market drawdown, we would expect quality to hold up well.

Specifically, relating our views back to the second quarter: While quality stocks underperformed, leadership was driven by speculative growth stocks. We believe this environment is not representative of how a sustained quality drawdown would unfold; rather, we expect that any sustained drawdown in quality would likely take place as the market broadens beyond high-quality large-cap growth stocks, and this environment would look different—and less speculative—than the second quarter.

Conclusion

Many clients have asked for our views on whether high-quality U.S. large-cap stocks are overpriced. We answer that question by applying the Integrated Equity framework—combining the outside and inside views. The outside view suggests that high quality is historically expensive and that similar periods in the past have led to significant underperformance of quality. However, the inside view suggests that there are economically driven reasons for these stocks to be more expensive, as high‑quality stocks are higher quality today than they’ve ever been. Also, the apparent expensiveness of quality today looks very different from what it did in previous episodes, and we therefore see the risk to high quality as more likely “modest underperformance” while funding a market rotation, as opposed to significant underperformance.

 

Appendix

Factors are our internally constructed metrics, defined as follows:

Valuation: Proprietary composite of valuation metrics based on earnings, sales, book value, and dividends. Specific value factor weighting may vary by region and sector.

Growth: Proprietary composite of growth metrics based on historical and forward‑looking earnings and sales growth. Factor selection and weighting vary by region and industry.

Momentum: Proprietary measure of medium‑term price momentum.

Quality: Proprietary measure of quality based on fundamental and stock price stability; balance sheet strength; and measures of profitability, capital usage, and earnings quality.

Profitability: Return on equity.

Risk: Proprietary composite capturing stock return stability over multiple time horizons (positive return means risky stocks outperform stable stocks).

Size: Market capitalization (positive return means larger stocks outperform smaller stocks).

Quintile spread: Also referred to as long-short returns, a quintile spread is calculated by sorting securities based on a specific characteristic or factor criterion, dividing them into five groups (or quintiles), equal-weighting the securities within each quintile, and then subtracting the bottom-quintile returns (lowest 20%) from the top-quintile returns (highest 20%).

Factors and indices cannot be invested in directly and are shown for illustrative purposes only. They do not reflect performance of actual investments nor do they reflect the reduction of fees associated with an actual investment, such as trading costs and management fees.

Additional Disclosures

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

© 2025 Refinitiv. All rights reserved.

MSCI and its affiliates and third party sources and providers (collectively, “MSCI”) makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed, or produced by MSCI. Historical MSCI data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.

MSCI Barra. Barra and its affiliates and third party sources and providers (collectively, “Barra”) makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any Barra data contained herein. The Barra data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed, or produced by Barra. Historical Barra data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. None of the Barra data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.

London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). © LSE Group 2025. FTSE Russell is a trading name of certain of the LSE Group companies. Russell® is a trade mark of the relevant LSE Group companies and is/are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication. The LSE Group is not responsible for the formatting or configuration of this material or for any inaccuracy in T. Rowe Price’s presentation thereof.

Copyright © 2025, S&P Global Market Intelligence (and its affiliates, as applicable). Reproduction of any information, data or material, including ratings (“Content”) in any form is prohibited except with the prior written permission of the relevant party. Such party, its affiliates and suppliers (“Content Providers”) do not guarantee the accuracy, adequacy, completeness, timeliness or availability of any Content and are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, or for the results obtained from the use of such Content. In no event shall Content Providers be liable for any damages, costs, expenses, legal fees, or losses (including lost income or lost profit and opportunity costs) in connection with any use of the Content. A reference to a particular investment or security, a rating or any observation concerning an investment that is part of the Content is not a recommendation to buy, sell or hold such investment or security, does not address the suitability of an investment or security and should not be relied on as investment advice. Credit ratings are statements of opinions and are not statements of fact.

T. Rowe Price calculations using data from FactSet Research Systems Inc. All rights reserved.

Refinitiv, Compustat, FTSE/Russell, MSCI, and Morningstar do not accept any liability for any errors or omissions in the indexes or data, and hereby expressly disclaim all warranties of originality, accuracy, completeness, timeliness, merchantability and fitness for a particular purpose. No party may rely on any indexes or data contained in this communication. Visit https://www.troweprice.com/marketdata for additional legal notices & disclaimers.

Important Information

This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a guarantee or a reliable indicator of future results. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass.

The views contained herein are as of July 2025 and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.

Australia—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. For Wholesale Clients only.

Canada—Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to non‑individual Accredited Investors and non-individual Permitted Clients as defined under National Instrument 45-106 and National Instrument 31-103, respectively. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services.

EEA—Unless indicated otherwise this material is issued and approved by T. Rowe Price (Luxembourg) Management S.à r.l. 35 Boulevard du Prince Henri L-1724 Luxembourg which is authorised and regulated by the Luxembourg Commission de Surveillance du Secteur Financier. For Professional Clients only.

New Zealand—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. No Interests are offered to the public. Accordingly, the Interests may not, directly or indirectly, be offered, sold or delivered in New Zealand, nor may any offering document or advertisement in relation to any offer of the Interests be distributed in New Zealand, other than in circumstances where there is no contravention of the Financial Markets Conduct Act 2013.

Switzerland—Issued in Switzerland by T. Rowe Price (Switzerland) GmbH, Talstrasse 65, 6th Floor, 8001 Zurich, Switzerland. For Qualified Investors only.

UK—This material is issued and approved by T. Rowe Price International Ltd, Warwick Court, 5 Paternoster Square, London EC4M 7DX which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only.

USA—Issued in the USA by T. Rowe Price Associates, Inc., 1307 Point Street, Baltimore, MD 21231, which is regulated by the U.S. Securities and Exchange Commission. For Institutional Investors only.

© 2025 T. Rowe Price. All Rights Reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, the Bighorn Sheep design, and related indicators (see troweprice.com/ip) are trademarks of T. Rowe Price Group, Inc. All other trademarks are the property of their respective owners.

202507‑4590268